Clearbridge Health Limited (5C6.F)
- Previous Close
0.0010 - Open
0.0010 - Bid 0.0010 x --
- Ask 0.0030 x --
- Day's Range
0.0010 - 0.0010 - 52 Week Range
0.0010 - 0.0080 - Volume
21,000 - Avg. Volume
0 - Market Cap (intraday)
4.356M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services. It also offers aesthetics, and dental and orthodontics services, as well as consultancy services for healthcare organization; and wholesales medicinal and pharmaceutical products. Clearbridge Health Limited was incorporated in 2010 and is based in Singapore.
www.clearbridgehealth.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 5C6.F
View MorePerformance Overview: 5C6.F
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 5C6.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 5C6.F
View MoreValuation Measures
Market Cap
4.36M
Enterprise Value
6.41M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.10
Price/Book (mrq)
0.35
Enterprise Value/Revenue
0.97
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-36.43%
Return on Assets (ttm)
-10.99%
Return on Equity (ttm)
-34.63%
Revenue (ttm)
9.9M
Net Income Avi to Common (ttm)
-3.72M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
4.88M
Total Debt/Equity (mrq)
56.44%
Levered Free Cash Flow (ttm)
-393.12k